Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mach7 Technologies ( (AU:M7T) ) has issued an update.
Mach7 Technologies Limited has announced an update on its ongoing on-market buy-back program. As of May 20, 2025, the company has repurchased a total of 4,320,000 ordinary fully paid securities, including 80,000 bought back on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative healthcare solutions. The company specializes in developing software for medical imaging and data management, catering to healthcare providers and institutions.
YTD Price Performance: -5.00%
Average Trading Volume: 260,572
Technical Sentiment Signal: Sell
Current Market Cap: A$91.67M
For detailed information about M7T stock, go to TipRanks’ Stock Analysis page.